BMY
Bristol-Myers Squibb Co
Price:  
49.74 
USD
Volume:  
7,566,644.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Bmy WACC - Weighted Average Cost of Capital

The WACC of Bristol-Myers Squibb Co (BMY) is 6.0%.

The Cost of Equity of Bristol-Myers Squibb Co (BMY) is 7.10%.
The Cost of Debt of Bristol-Myers Squibb Co (BMY) is 4.25%.

Range Selected
Cost of equity 6.10% - 8.10% 7.10%
Tax rate 16.00% - 22.80% 19.40%
Cost of debt 4.00% - 4.50% 4.25%
WACC 5.3% - 6.8% 6.0%
WACC

Bmy WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.48 0.58
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.10% 8.10%
Tax rate 16.00% 22.80%
Debt/Equity ratio 0.4 0.4
Cost of debt 4.00% 4.50%
After-tax WACC 5.3% 6.8%
Selected WACC 6.0%